299 results on '"Corbacioglu, S."'
Search Results
2. Sturz vom Wickeltisch: Besonderheiten, die zu beachten sind
3. The first steps towards a diverse and inclusive EBMT: a position paper
4. Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation
5. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
6. 5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE
7. Sturz vom Wickeltisch
8. Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group
9. Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major
10. Haematopoietic stem cell transplantation for severe autoimmune diseases in children : a review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation
11. State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29–30 September 2015
12. Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study
13. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
14. Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians
15. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey
16. Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
17. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes
18. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus
19. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients : a position statement from an international expert group
20. Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
21. Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation
22. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
23. Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party
24. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes
25. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
26. Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/s41409-020-0854-0)
27. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
28. Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (Bone Marrow Transplantation, (2020), 55, 11, (2071-2076), 10.1038/s41409-020-0919-0)
29. Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice
30. HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH CD3+/19+ DEPLETED PBSC FOR ADVANCED STAGE SICKLE CELL DISEASE: PH-P447
31. Stem cell transplantation in children: how to design a new study
32. Can we estimate cytokine storm from initial computed tomography images of Coronavirus disease-2019 patients?
33. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide
34. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
35. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention
36. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita
37. Lebervenenverschlusserkrankung im Kindesalter
38. WISKOTT ALDRICH SYNDROME WITHOUT MICRO THROMBOCYTOPENIA? NOTES FOR NEW MUTATION: 178
39. AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AS A THERAPEUTIC OPTION FOR PATIENTS WITH SEVERE SYSTEMIC SCLERODERMA: 169
40. SUCCESSFUL CORD BLOOD TRANSPLANTATION WITH MULTIPLE MISMATCH FOR DYSKERATOSIS CONGENITA AND TINF2-MUTATION: 208
41. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders : current practice in Europe, 2019
42. The prospective study on the incidence and outcome of VOD with the prophylactic use of defibrotide in paediatric stem cell transplantation has completed enrolment: update on the VOD-DF Study: 239
43. Update on the Phase II/III study of the incidence and outcome of VOD with the prophylactic use of defibrotide in paediatric stem cell transplantation (VOD-DF Study)
44. Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant
45. Gemtuzumab Ozogamicin (Mylotarg®) in Children with Refractory or Relapsed Acute Myeloid Leukemia
46. Identification of patients with classical and/or cryptic dyskeratosis congenita (DKC) by telomere length screening using different percentiles : results from the Aachen telomeropathy registry
47. Management of veno-occlusive disease: the multidisciplinary approach to care
48. Erratum: Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention
49. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation
50. An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.